- Preclinical Data Suggest Novel Molecule Enhances Immunotherapy Response in CRC – OncLive
- Immune ‘cloaking’ in cancer cells and implications for immunotherapy – EurekAlert
- Revitope Oncology Adds Carsten Reinhardt, a Pioneer of Modern Immunotherapy, to its Board of Directors – PRNewswire
- Revitope Oncology Adds Carsten Reinhardt, a Pioneer of Modern Immunotherapy, to its Board of Directors – PRNewswire
- Culprit Behind Immunotherapy Resistance in Some Lymphomas Revealed – Genetic Engineering & Biotechnology News
- Younger Adults, Women with Cancer Respond Less Well to Immunotherapy with Checkpoint Inhibitors – Curetoday.com
- Revitope Oncology Adds Carsten Reinhardt, a Pioneer of Modern Immunotherapy, to its Board of Directors – PRNewswire
- Adding Immunotherapy to Radiotherapy Increases Survival in Patients with Brain Metastases – Curetoday.com
- Revitope Oncology Adds Carsten Reinhardt, a Pioneer of Modern Immunotherapy, to its Board of Directors – PRNewswire
- Revitope Oncology Adds Carsten Reinhardt, a Pioneer of Modern Immunotherapy, to its Board of Directors – PRNewswire